EPLUS INC (PLUS) director granted 1,478 restricted shares

Melissa J. Ballenger, a director of EPLUS INC (PLUS), was granted 1,478 shares of restricted common stock on 10/01/2025 under the company’s 2024 Non-Employee Director Long Term Incentive Plan.

Rhea-AI Filing Summary

Melissa J. Ballenger, a director of EPLUS INC (PLUS), was granted 1,478 shares of restricted common stock on 10/01/2025 under the company’s 2024 Non-Employee Director Long Term Incentive Plan. The award carries a one‑year restriction period that begins on the grant date, after which restrictions may lapse or, under certain circumstances described in the plan, the shares may be forfeited and returned to the company. Following this grant, Ms. Ballenger beneficially owns 2,525 shares. The reported acquisition price is $0, and the Form 4 was signed on 10/03/2025.

Positive

• Director grant of 1,478 restricted shares recorded on 10/01/2025
• Total beneficial ownership increased to 2,525 shares after the award

Negative

• None.

Insider Trade Summary

Grant/Award: 1,478 shares

Grant/Award 1 txn

Insider Ballenger Melissa J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,478	$0.00	$0.00

Holdings After Transaction: Common Stock — 2,525 shares (Direct)

Footnotes (1)

1. F1. This restricted stock award consists of shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period beginning on the grant date and ending on the first anniversary of the grant (the "Restriction Period"). As more fully described in the Plan, under certain other circumstances the restrictions may lapse, or the shares may be forfeited and transferred back to the Company.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Melissa J. Ballenger report on Form 4 for PLUS?

She reported a grant of 1,478 restricted shares of EPLUS INC common stock on 10/01/2025 under the 2024 Non-Employee Director Long Term Incentive Plan.

How many shares does the reporting person own after the transaction?

Following the reported transaction, Melissa J. Ballenger beneficially owns 2,525 shares.

What are the terms of the restricted shares granted?

The restricted shares are subject to a Restriction Period ending on the first anniversary of the grant; restrictions may lapse or shares may be forfeited under circumstances set by the plan.

Was there any cash paid for the restricted shares?

The reported acquisition price for the restricted shares is $0.

When was the Form 4 signed and filed?

The Form 4 bears the reporting person’s signature dated 10/03/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/03/2025 - 05:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ballenger Melissa J

(Last) (First) (Middle)

13595 DULLES TECHNOLOGY DRIVE

(Street)

HERNDON VA 20171-3413

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EPLUS INC [ PLUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		A		1,478(1)	A	$0	2,525	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This restricted stock award consists of shares of common stock of the Company (the "Restricted Shares"). The Restricted Shares were granted pursuant to the Company's 2024 Non-Employee Director Long Term Incentive Plan (the "Plan") and are subject to a Restriction Period beginning on the grant date and ending on the first anniversary of the grant (the "Restriction Period"). As more fully described in the Plan, under certain other circumstances the restrictions may lapse, or the shares may be forfeited and transferred back to the Company.

	/s/ Melissa J. Ballenger	10/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.